Why is Aarti Pharma falling/rising?

As of 12-Sep, Aarti Pharmalabs Ltd is experiencing a price increase, with the current price at Rs 926.55, reflecting a rise of Rs 16.55 or 1.82%. The stock has shown strong performance, gaining 4.87% over the past week and 8.28% over the past month, significantly outperforming the Sensex, which has increased by only 1.48% and 2.08% respectively during the same periods. Additionally, the stock is trading close to its 52-week high, just 4.85% away from Rs 971.5, and has been on a positive trend for the last two days, accumulating a total return of 2.83%. The company maintains a low Debt to EBITDA ratio of 0.63 times, indicating a strong ability to service its debt, and its attractive valuation is supported by a Return on Capital Employed (ROCE) of 16.1 and a PEG ratio of 1.7.
In the broader market context, Aarti Pharmalabs has outperformed the BSE500 index, which has seen negative returns of -3.45% over the past year, while the stock itself has generated a remarkable return of 38.54%. This performance highlights the company's resilience and market-beating capabilities despite a challenging market environment. However, it is worth noting that investor participation has decreased, with delivery volume falling by 16.95% against the five-day average, which could indicate a potential concern for future trading activity. Overall, the stock's strong fundamentals and recent performance contribute positively to its rising price, even as liquidity concerns may warrant attention.